Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, provides drug discovery and development services in Japan and internationally. It offers pre-clinical laboratory services, such as good laboratory practice inspections; general and specific toxicity studies; pathological examinations; PK/PD of biopharmaceuticals, immunotoxicity tests, and antibody production; reproductive and developmental toxicity studies; pharmacology and pharmacological efficacy studies; and imaging services. The company also engages in the establishment and validation of analytical methods, analysis of biological samples, and calculation of pharmacokinetic parameters; and provides absorption, distribution, metabolism, and excretion studies using radioisotope-labeled compounds. In addition, it provides site management organization services for clinical trials; clinical contract research organization services; and translational research services, including research and development of nasal delivery systems, nucleic acid adjuvants, and regenerative medicines. The company was founded in 1957 and is headquartered in Tokyo, Japan.

Dr. Hideshi  Tsusaki DVM Ph.D.

Senior MD, President of Non-Clinical & Global Business Development and Director

Toshiyuki  Iwata

Managing Executive Officer and GM of IR Public Relations Department & Sustainability

Shinji  Nitanda

Senior MD of Corporate Development & Corporate Tax Administration and Director

Terumasa  Hirai

Managing Executive Officer, Preclinical Company Vice President & Director of Safety Research Institute

Mr. Eishi  Tsunozaki

Senior MD & Director

Satoshi  Matsumoto

Managing Executive Officer & GM of Fisheries Division

Dr. Ryoichi  Nagata F.F.P.M., M.D., Ph.D.

Chairman, Chief Executive Officer, President, Head of Fisheries Business & CHO

Fumihiko  Makino

Senior Executive Officer, Financial Controller and GM of Finance & Accounting

Kyomi  Nagatoshi

Managing Executive Officer, Head of General Affairs & Human Resources and Director

Mr. Ken  Takanashi CPA, MBA.

Executive Vice President of Group Corporate Management & Global Business & Director

Nom de l'entreprise	Capitalisation boursière
Thyrocare Technologies Limited	0M
China Health Group Inc.	0M
Revvity, Inc.	0M
Sotera Health Company	0M
Standard BioTools Inc.	0M
IDEXX Laboratories, Inc.	0M
Abingdon Health Plc	0M
China Biotech Services Holdings Limited	0M
Sonic Healthcare Limited	0M
Quest Diagnostics Incorporated	0M
Qiagen N.V.	0M

Shin Nippon Biomedical Laboratories, Ltd.

Shin Nippon Biomedical Laboratories, Ltd. Liste des concurrents

Principaux concurrents